Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* At term (37 to 42 weeks inclusive gestation).~* Aged 18 years or older.~* One previous full term delivery (at least 37 weeks gestation).~* Singleton pregnancy.~* Cephalic presentation (normal lie).~* Bishop score more than 6 as determined by MBS criteria.~* Uncomplicated pregnancy as judged by the physician.~* Written informed consent.~Exclusion Criteria:~* four previous full term deliveries.~* Previous uterine surgery, including C-section and surgery to the cervix of the uterus (cone biopsy of the cervix is permitted).~* In spontaneous labour.~* Administration of oxytocin or a tocolytic drug or any other cervical ripening or labour inducing agent prior to enrolment (within seven days of enrolment).~* Suspected cephalo-pelvic disproportion.~* Evidence or suggestion of fetal distress.~* Subject has received NSAID (including aspirin) within four hours of study treatment (topical is permitted).~* Pyrexia (oral or aural temperature \> 37.5C).~* Unexplained genital bleeding during this pregnancy after 24 weeks.~* Current pelvic inflammatory disease, unless adequate prior treatment has been instituted.~* Placenta praevia.~* Known or suspected allergy to misoprostol or other prostaglandins.~* Prior serious adverse event related to prostaglandin administered by any route for any indication.~* Subject unable to comply with the requirements of the protocol.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MVI 25 (Type: EXPERIMENTAL): Misoprostol vaginal insert 25 mcg
- MVI 50 (Type: EXPERIMENTAL): Misoprostol vaginal insert 50 mcg
- MVI 100 (Type: EXPERIMENTAL): Misoprostol vaginal insert 100 mcg
- MVI 200 (Type: EXPERIMENTAL): Misoprostol vaginal insert 200 mcg

Based on this trial design, predict the completion outcome and termination type (if applicable).